Slide Insurance CEO-linked entity sells 998K shares
Slide Insurance Holdings, Inc. director and CEO Lucas Bruce reported indirect open-market sales of the company’s common stock by an entity he controls.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. director and CEO Lucas Bruce reported indirect open-market sales of the company’s common stock by an entity he controls. IIM Holdings II, LLC sold a total of 997,881 shares between May 15–19, 2026 at weighted-average prices in ranges from about $18.75 to $19.27 per share, under a pre-established Rule 10b5-1 trading plan.
After these sales, IIM Holdings II, LLC held 35,156,165 shares of Slide Insurance common stock. Additional indirect holdings include shares held by Bruce’s spouse and through family trusts, and Bruce also reported 1,151,445 shares held directly as of May 15, 2026.
Insights
Pre-planned insider sales by CEO-linked entity, while large in size, leave substantial holdings intact.
The filing shows IIM Holdings II, LLC, an entity controlled by CEO Lucas Bruce, sold 997,881 shares of Slide Insurance common stock in open-market transactions between May 15–19, 2026. Sale prices ranged roughly from $18.75 to $19.27 per share, based on weighted-average disclosures.
A key detail is that these sales were executed under a Rule 10b5-1 trading plan adopted on November 21, 2025. Such plans are set up in advance, so the timing of trades is less informative about management’s short-term view of the stock.
Following the trades, IIM Holdings II, LLC still held 35,156,165 shares, and Bruce reported additional direct and family-trust holdings. Given the remaining position and the pre-planned nature of the sales, the activity appears routine rather than thesis-changing for Slide Insurance’s equity story.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 273,000 | $18.97 | $5.18M |
| Sale | Common Stock | 455,000 | $19.06 | $8.67M |
| Sale | Common Stock | 269,881 | $18.84 | $5.08M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (10)
- F1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
- F2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $19.02 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F3. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F4. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.90 to $19.27 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F5. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $19.07 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F6. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F7. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 98,692 shares of common stock between May 15-19, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.75 to $19.27 per share.
- F8. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F9. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F10. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
beneficial ownership regulatory
pecuniary interest financial
Section 16 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock sales did Slide Insurance (SLDE) disclose in this Form 4?
Were the SLDE insider stock sales by Lucas Bruce pre-planned under Rule 10b5-1?
AI-generated analysis. How Rhea-AI works. Not financial advice.